Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
28,234,434
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
3,481,751
-
Shares change
-
-1,258,009
-
Total reported value, excl. options
-
$45,435,169
-
Value change
-
-$14,747,696
-
Put/Call ratio
-
11%
-
Number of buys
-
22
-
Number of sells
-
-41
-
Price
-
$13.05
Significant Holders of ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) as of Q2 2022
75 filings reported holding CLPT - ClearPoint Neuro, Inc. - Common Stock, $0.01 par value as of Q2 2022.
ClearPoint Neuro, Inc. - Common Stock, $0.01 par value (CLPT) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,481,751 shares
of 28,234,434 outstanding shares and own 12% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (980,062 shares), BROWN ADVISORY INC (328,015 shares), BlackRock Inc. (297,585 shares), MILLENNIUM MANAGEMENT LLC (190,546 shares), Taylor Frigon Capital Management LLC (174,726 shares), GEODE CAPITAL MANAGEMENT, LLC (171,521 shares), MORGAN STANLEY (127,589 shares), CM Management, LLC (125,000 shares), PARSONS CAPITAL MANAGEMENT INC/RI (109,648 shares), and ESSEX INVESTMENT MANAGEMENT CO LLC (105,590 shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.